All registered PharmasAlmanac.com users have exclusive access to the PPD Decentralized Clinical Trials Survey, featuring insights from global pharmaceutical leaders on data quality from decentralized trials, future plans for hybrid and decentralized trials, and much more.
Julie Meno
Every manufacturer has a common and straightforward goal — to extend the value of capital equipment investments and achieve maximum return on those investments. While these goals are easily ...
Jeremy Tatum
A recently published study,1 sponsored by TriRx Pharmaceutical Services and conducted in 2021, explores current challenges, trends, and needs facing animal health organizations, as well as the ...
David Alvaro, Ph.D.
Representatives from start-up development company Wheeler Bio and its digitalization partners, DataHow and Synthace, discuss how their collaboration will help Wheeler gain deeper insights into ...
Giorgio Bertolini, Ph.D., Giorgio Bertolini, Ph.D.
Following a busy few years of acquisitions, Olon has announced the creation of a major new global research and development (R&D) hub at its headquarters in Rodano, Italy, which will form the ...
Andrea Engel, Ph.D., Philipp Heller, Ph.D.
The mRNA-based COVID-19 vaccines were made possible through the use of lipid nanoparticles (LNPs) as delivery vehicles to protect the mRNA from degradation and to aid intracellular delivery and ...
Atef Khezri
Process development and manufacturing for viral vectors intended for cell and gene therapies present unique quality and safety challenges requiring rigorous quality culture and systems and ...
Thilo Kamphausen, Ph.D., Kai Pohlmeyer
With 30 years of experience manufacturing plasmid DNA (pDNA), Richter-Helm has gained an unparalleled amount of first-hand knowledge that they apply to each customer project, regardless of phase ...
Andrea Baiocchi, Marco Scanziani
The pandemic has significantly affected the pharmaceutical industry, including the contract manufacturing segment. CMOs with flexibility, agility, and speed combined with the ability to form ...
Aniruddha Bose
As biopharma manufacturing shifts from pre-digital processes to more digital ones, technology providers will develop intensified bioprocessing technologies together with software, automation, ...
Prof. Dr. Ulrike Fiedler, Rob Burgess, Ph.D.,Amy Sheng, Ph.D., Lillith Elmore
The demand for vaccine, cell and gene therapeutics, and biologic manufacturing has increased dramatically in recent years, in part due to the need to produce billions of doses of COVID-19 ...
Mark Shlomchik, M.D., Ph.D.
The next generation of oncology treatments will likely require a personalized approach wherein a patient’s own immune system will be harnessed to specifically tackle their unique cancer cells. ...
Amy Sheng, Ph.D., Rob Burgess, Ph.D.,Amy Sheng, Ph.D., Lillith Elmore
Demand for antibodies continues to rise as new drug targets are constantly being discovered and new formats that address the shortcomings of traditional monoclonal antibodies progress through ...
Trond Erik Vee Aune, Ph.D.
Reaching the clinic as quickly as possible is only beneficial if you get there having already established an optimized, robust, and scalable production process. For simple to complex proteins ...
The Pharma’s Almanac editorial team is very excited to present our Q2 digital issue. This issue includes new content from our team and our colleagues at Nice Insight, as well as a large number of incredible subject matter experts from across the pharma/biopharma ecosystem, including drug discovery and development companies, life science industrials, technology providers, and contract development and manufacturing organizations. The diverse selection of topics touches on a huge spectrum of topics, united by the central thread of innovations that are ushering in the future of the industry.
Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac.
View Full Company Directory